CaRe Clinic Joins hyperCORE International's Expanding Global Network

hyperCORE International has announced that CaRe Clinic, a multi-specialty research organization based in Alberta, Canada, has joined its super network of clinical trial sites. This partnership aims to enhance hyperCORE's global reach and capabilities through strategic alliances.

CaRe Clinic operates two state-of-the-art research centers in Calgary and Red Deer, covering central regions of Alberta. The organization has participated in hundreds of clinical trials across various medical fields, including women's health, dermatology, general medicine, vaccines, infectious diseases, and migraine treatments. With access to a database of over 1.8 million potential patients, CaRe Clinic's community-centric recruitment strategy has fostered significant potential for participant engagement across diverse medical indications.

Troy Hamilton, Director of Operations at CaRe Clinic, emphasized the importance of this partnership, stating, "Joining hyperCORE International was a chance to improve how we deliver clinical trials. This partnership opens doors for unprecedented collaboration and the sharing of best practices across borders, which is crucial for the advancement of clinical research. We aim to highlight Canada's robust clinical research ecosystem on the global stage and contribute to pioneering breakthroughs that will benefit patients worldwide."

Carlos Orantes, President of hyperCORE and CEO at alliance partner Alcanza Clinical Research, expressed enthusiasm about the new partnership. "hyperCORE welcomes CaRe Clinic to their super network with open arms. This immediately increases hyperCORE's footprint at multiple locations in Canada with a multi-therapeutic offering and adds a solid partner to the team. We are excited to start working closely with the CaRe Clinic team!"

hyperCORE International is a leading network of clinical research site companies, providing Phase I-IV clinical trial services with more than 120 active research sites across two continents and five countries. The network's alliance partners have decades of clinical research experience, having collectively completed over 7,000 studies and evaluated thousands of new drugs and treatments in more than 150,000 randomized patients. Each partner operates independently while integrating common functions to streamline business and clinical operations through harmonization and best practice sharing.

hyperCORE International is committed to maintaining the highest standards of research excellence, prioritizing subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention. Its members have received numerous awards for performance, quality, and innovation.